Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Rates of cerebral protein synthesis in primary visual cortex during sleep-dependent memory consolidation, a study in human subjects.

Picchioni D, Schmidt KC, McWhirter KK, Loutaev I, Pavletic AJ, Speer AM, Zametkin AJ, Miao N, Bishu S, Turetsky KM, Morrow AS, Nadel JL, Evans BC, Vesselinovitch DM, Sheeler CA, Balkin TJ, Smith CB.

Sleep. 2018 Jul 1;41(7). doi: 10.1093/sleep/zsy088.

2.

Cases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.

Keil MF, Zametkin A, Ryder C, Lodish M, Stratakis CA.

Pediatrics. 2016 Apr;137(4). pii: e20152234. doi: 10.1542/peds.2015-2234. Epub 2016 Mar 29.

3.

A PILOT STUDY ON THE ENCODING OF A PERCEPTUAL LEARNING TASK FOLLOWING SLEEP DEPRIVATION.

McWhirter KK, Morrow AS, Lee BA, Bishu S, Zametkin AJ, Balkin TJ, Smith CB, Picchioni D.

Percept Mot Skills. 2015 Aug;121(1):80-93. doi: 10.2466/23.PMS.121c11x9. Epub 2015 Jul 30.

4.

Voluntary exercise regionally augments rates of cerebral protein synthesis.

Nadel J, Huang T, Xia Z, Burlin T, Zametkin A, Smith CB.

Brain Res. 2013 Nov 6;1537:125-31. doi: 10.1016/j.brainres.2013.09.001. Epub 2013 Sep 7.

5.

Altered cerebral protein synthesis in fragile X syndrome: studies in human subjects and knockout mice.

Qin M, Schmidt KC, Zametkin AJ, Bishu S, Horowitz LM, Burlin TV, Xia Z, Huang T, Quezado ZM, Smith CB.

J Cereb Blood Flow Metab. 2013 Apr;33(4):499-507. doi: 10.1038/jcbfm.2012.205. Epub 2013 Jan 9.

6.

Dopamine reward pathway in adult ADHD.

Zametkin AJ.

JAMA. 2010 Jan 20;303(3):232-3; author reply 233-4. doi: 10.1001/jama.2009.1998. No abstract available.

PMID:
20085952
7.

Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-(11)C]leucine and PET in healthy male subjects.

Bishu S, Schmidt KC, Burlin TV, Channing MA, Horowitz L, Huang T, Liu ZH, Qin M, Vuong BK, Unterman AJ, Xia Z, Zametkin A, Herscovitch P, Quezado Z, Smith CB.

J Cereb Blood Flow Metab. 2009 May;29(5):1035-47. doi: 10.1038/jcbfm.2009.7. Epub 2009 Feb 18.

8.

Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility.

Bishu S, Schmidt KC, Burlin T, Channing M, Conant S, Huang T, Liu ZH, Qin M, Unterman A, Xia Z, Zametkin A, Herscovitch P, Smith CB.

J Cereb Blood Flow Metab. 2008 Aug;28(8):1502-13. doi: 10.1038/jcbfm.2008.43. Epub 2008 May 21.

9.

Modulation of emotion by cognition and cognition by emotion.

Blair KS, Smith BW, Mitchell DG, Morton J, Vythilingam M, Pessoa L, Fridberg D, Zametkin A, Sturman D, Nelson EE, Drevets WC, Pine DS, Martin A, Blair RJ.

Neuroimage. 2007 Mar;35(1):430-40. Epub 2007 Jan 18.

10.

Choice selection and reward anticipation: an fMRI study.

Ernst M, Nelson EE, McClure EB, Monk CS, Munson S, Eshel N, Zarahn E, Leibenluft E, Zametkin A, Towbin K, Blair J, Charney D, Pine DS.

Neuropsychologia. 2004;42(12):1585-97.

PMID:
15327927
11.

Psychiatric aspects of child and adolescent obesity: a review of the past 10 years.

Zametkin AJ, Zoon CK, Klein HW, Munson S.

J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):134-50. Review.

PMID:
14726719
12.

Suicide in teenagers: assessment, management, and prevention.

Zametkin AJ, Alter MR, Yemini T.

JAMA. 2001 Dec 26;286(24):3120-5.

PMID:
11754678
13.

Aggression and psychiatric comorbidity in children with hypothalamic hamartomas and their unaffected siblings.

Weissenberger AA, Dell ML, Liow K, Theodore W, Frattali CM, Hernandez D, Zametkin AJ.

J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):696-703.

PMID:
11392348
14.

Case study: sexual hyperactivity treated with psychostimulants in familial male precocious puberty.

Weissenberger AA, Leschek EW, Zametkin AJ.

J Am Acad Child Adolesc Psychiatry. 2001 Mar;40(3):373-6.

PMID:
11288780
15.

Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts.

Kling MA, Carson RE, Borg L, Zametkin A, Matochik JA, Schluger J, Herscovitch P, Rice KC, Ho A, Eckelman WC, Kreek MJ.

J Pharmacol Exp Ther. 2000 Dec;295(3):1070-6.

PMID:
11082442
16.

Adrenergic and noradrenergic plasma levels in Lesch-Nyhan disease.

Ernst M, Zametkin AJ, Pascualvaca D, Matochik JA, Eisenhofer G, Murphy DL, Cohen RM.

Neuropsychopharmacology. 2000 Mar;22(3):320-6.

17.

High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Cohen RM.

Am J Psychiatry. 1999 Aug;156(8):1209-15.

PMID:
10450262
18.

High presynaptic dopaminergic activity in children with Tourette's disorder.

Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM.

J Am Acad Child Adolesc Psychiatry. 1999 Jan;38(1):86-94.

PMID:
9893421
19.

Problems in the management of attention-deficit-hyperactivity disorder.

Zametkin AJ, Ernst M.

N Engl J Med. 1999 Jan 7;340(1):40-6. Review. No abstract available.

PMID:
9878644
20.

Regional cerebral metabolic asymmetries replicated in an independent group of patients with panic disorders.

Nordahl TE, Stein MB, Benkelfat C, Semple WE, Andreason P, Zametkin A, Uhde TW, Cohen RM.

Biol Psychiatry. 1998 Nov 15;44(10):998-1006.

PMID:
9821564
21.

The neurobiology of attention-deficit/hyperactivity disorder.

Zametkin AJ, Liotta W.

J Clin Psychiatry. 1998;59 Suppl 7:17-23. Review.

22.
23.

Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?

Murphy DL, Sims K, Eisenhofer G, Greenberg BD, George T, Berlin F, Zametkin A, Ernst M, Breakefield XO.

J Neural Transm Suppl. 1998;52:29-38.

PMID:
9564605
24.

Age-related changes in brain glucose metabolism in adults with attention-deficit/hyperactivity disorder and control subjects.

Ernst M, Zametkin AJ, Phillips RL, Cohen RM.

J Neuropsychiatry Clin Neurosci. 1998 Spring;10(2):168-77.

PMID:
9608405
25.

Laboratory and diagnostic testing in child and adolescent psychiatry: a review of the past 10 years.

Zametkin AJ, Ernst M, Silver R.

J Am Acad Child Adolesc Psychiatry. 1998 May;37(5):464-72. Review.

PMID:
9585646
26.
27.

Cerebral glucose metabolism in childhood onset schizophrenia.

Jacobsen LK, Hamburger SD, Van Horn JD, Vaituzis AC, McKenna K, Frazier JA, Gordon CT, Lenane MC, Rapoport JL, Zametkin AJ.

Psychiatry Res. 1997 Oct 31;75(3):131-44.

PMID:
9437771
28.

Intravenous dextroamphetamine and brain glucose metabolism.

Ernst M, Zametkin AJ, Matochik J, Schmidt M, Jons PH, Liebenauer LL, Hardy KK, Cohen RM.

Neuropsychopharmacology. 1997 Dec;17(6):391-401.

29.

Cerebral glucose metabolism in adolescent girls with attention-deficit/hyperactivity disorder.

Ernst M, Cohen RM, Liebenauer LL, Jons PH, Zametkin AJ.

J Am Acad Child Adolesc Psychiatry. 1997 Oct;36(10):1399-406.

PMID:
9334553
30.

Low medial prefrontal dopaminergic activity in autistic children.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM.

Lancet. 1997 Aug 30;350(9078):638. No abstract available. Erratum in: Lancet 1998 Feb 7;351(9100):454.

PMID:
9288051
31.

Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.

Hommer D, Andreasen P, Rio D, Williams W, Ruttimann U, Momenan R, Zametkin A, Rawlings R, Linnoila M.

J Neurosci. 1997 Apr 15;17(8):2796-806.

32.

Gender differences in brain metabolic and plasma catecholamine responses to alpha 2-adrenoceptor blockade.

Schmidt ME, Matochik JA, Goldstein DS, Schouten JL, Zametkin AJ, Potter WZ.

Neuropsychopharmacology. 1997 Apr;16(4):298-310.

33.

Selegiline in ADHD adults: plasma monoamines and monoamine metabolites.

Ernst M, Liebenauer LL, Tebeka D, Jons PH, Eisenhofer G, Murphy DL, Zametkin AJ.

Neuropsychopharmacology. 1997 Apr;16(4):276-84.

34.

Use of propofol anesthesia during outpatient radiographic imaging studies in patients with Lesch-Nyhan syndrome.

Williams KS, Hankerson JG, Ernst M, Zametkin A.

J Clin Anesth. 1997 Feb;9(1):61-5.

PMID:
9051548
35.

Follow-up of radial arterial catheterization for positron emission tomography studies.

Jons PH, Ernst M, Hankerson J, Hardy K, Zametkin AJ.

Hum Brain Mapp. 1997;5(2):119-23.

PMID:
10096416
36.

Differential inhibition of neuronal and extraneuronal monoamine oxidase.

Eisenhofer G, Lenders JW, Harvey-White J, Ernst M, Zametkin A, Murphy DL, Kopin IJ.

Neuropsychopharmacology. 1996 Sep;15(3):296-301.

37.

Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions.

Schmidt ME, Ernst M, Matochik JA, Maisog JM, Pan BS, Zametkin AJ, Potter WZ.

J Nucl Med. 1996 Jul;37(7):1142-9.

38.

Presynaptic dopaminergic deficits in Lesch-Nyhan disease.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Jons PH, Hardy K, Hankerson JG, Doudet DJ, Cohen RM.

N Engl J Med. 1996 Jun 13;334(24):1568-72.

39.

Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone.

Matochik JA, Zametkin AJ, Cohen RM, Hauser P, Weintraub BD.

Brain Res. 1996 Jun 3;723(1-2):23-8.

PMID:
8813378
40.

Selegiline in adults with attention deficit hyperactivity disorder: clinical efficacy and safety.

Ernst M, Liebenauer LL, Jons PH, Tebeka D, Cohen RM, Zametkin AJ.

Psychopharmacol Bull. 1996;32(3):327-34.

PMID:
8961775
41.

Ethical issues in biological psychiatric research with children and adolescents.

Arnold LE, Stoff DM, Cook E Jr, Cohen DJ, Kruesi M, Wright C, Hattab J, Graham P, Zametkin A, Castellanos FX, et al.

J Am Acad Child Adolesc Psychiatry. 1995 Jul;34(7):929-39. Review.

PMID:
7649964
42.

Attention-deficit disorder. Born to be hyperactive?

Zametkin AJ.

JAMA. 1995 Jun 21;273(23):1871-4. No abstract available.

PMID:
7776505
43.

Regional brain glucose metabolism after acute alpha 2-blockade by idazoxan.

Schmidt ME, Matochik JA, Risinger RC, Schouten JL, Zametkin AJ, Cohen RM, Potter WZ.

Clin Pharmacol Ther. 1995 Jun;57(6):684-95.

PMID:
7781269
44.

Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.

Matochik JA, Molchan SE, Zametkin AJ, Warden DL, Sunderland T, Cohen RM.

Acta Neurol Scand. 1995 Feb;91(2):153-7.

PMID:
7785428
45.

Right frontotemporal activation by tonal memory in dyslexia, an O15 PET Study.

Rumsey JM, Andreason P, Zametkin AJ, King AC, Hamburger SD, Aquino T, Hanahan AP, Pikus A, Cohen RM.

Biol Psychiatry. 1994 Aug 1;36(3):171-80.

PMID:
7948454
46.

Reduced brain metabolism in hyperactive girls.

Ernst M, Liebenauer LL, King AC, Fitzgerald GA, Cohen RM, Zametkin AJ.

J Am Acad Child Adolesc Psychiatry. 1994 Jul-Aug;33(6):858-68.

PMID:
8083143
47.

ADHD and the thyroid controversy.

Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, Weintraub BD.

J Am Acad Child Adolesc Psychiatry. 1994 Jun;33(5):756-8. No abstract available.

PMID:
8056740
48.

Cerebral glucose metabolism in adults with attention deficit hyperactivity disorder after chronic stimulant treatment.

Matochik JA, Liebenauer LL, King AC, Szymanski HV, Cohen RM, Zametkin AJ.

Am J Psychiatry. 1994 May;151(5):658-64.

PMID:
8166305
49.

A double FDG/PET study of the effects of scopolamine in older adults.

Molchan SE, Matochik JA, Zametkin AJ, Szymanski HV, Cantillon M, Cohen RM, Sunderland T.

Neuropsychopharmacology. 1994 May;10(3):191-8.

50.

Gender-related differences in regional cerebral glucose metabolism in normal volunteers.

Andreason PJ, Zametkin AJ, Guo AC, Baldwin P, Cohen RM.

Psychiatry Res. 1994 Feb;51(2):175-83.

PMID:
8022952

Supplemental Content

Loading ...
Support Center